Skip to content
healthcare.dev

Chlordiazepoxide Hydrochloride and Clidinium Bromide

NDC 75826-134, Chlordiazepoxide Hydrochloride and Clidinium Bromide, capsule, from Winder Laboratories LLC.

Product NDC
75826-134
Status
Listed
Labeler
Winder Laboratories LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212344
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75826-134 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHLORDIAZEPOXIDE HYDROCHLORIDE5 mg/1
  • CLIDINIUM BROMIDE2.5 mg/1

Pharmacologic classes

Anticholinergic [EPC]; Benzodiazepine [EPC]; Benzodiazepines [CS]; Cholinergic Antagonists [MoA]; Decreased Parasympathetic Acetylcholine Activity [PE]; Digestive/GI System Activity Alteration [PE]; GI Motility Alteration [PE]

Package NDCNDC-11Package
75826-134-1075826013410100 CAPSULE in 1 BOTTLE, PLASTIC (75826-134-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/87d1a147-d3c3-4097-aac0-4b19c49eabe3

Use it

Look up 75826-134 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75826-134 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75826-134. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.